Romania – Antianaemic preparations – Framework agreement for the supply of medicines for the NATIONAL RENAL FUNCTION REPLACEMENT PROGRAM

Opportunity description

Framework agreement for the supply of medicines for the National Renal Function Replacement Program. The minimum and maximum quantities of the framework agreement and of the subsequent contracts are provided in the Specifications. The minimum estimated value of the framework agreement, the maximum estimated value of the framework agreement, as well as the estimated value of the largest subsequent contract are provided in the Specifications. Subsequent contracts will be concluded on the basis of the supply framework agreement, depending on the budgetary funds allocated for this purpose, the largest subsequent contract being estimated to be monthly or for any period covered by the available budget. HEPARINUM 5000 UI/ml * 5 ml. Estimated quantity for the largest subsequent contract 500 vials. Estimated value of the largest subsequent contract 15.040,00 lei excluding VAT. Minimum estimated quantity under the framework agreement 10.000 vials. Minimum estimated value of the framework agreement 300.800,00 lei excluding VAT. Maximum estimated quantity under the framework agreement 12.000 vials.Maximum estimated value of the framework agreement 360.960,00 lei excluding VAT. Orders will be placed depending on stock and requirements. CINACALCET 30 mg. Estimated quantity for the largest subsequent contract 40 tablets. Estimated value of the largest subsequent contract 237,60 lei excluding VAT. Minimum estimated quantity under the framework agreement 800 tablets. Minimum estimated value of the framework agreement 4.752,00 lei excluding VAT. Maximum estimated quantity under the framework agreement 1.000 tablets. Maximum estimated value of the framework agreement 5.940,00 lei excluding VAT. Orders will be placed depending on stock and requirements. EPOETINUM ALFA 4000 UI/0,4 ml. Estimated quantity for the largest subsequent contract 600 syringes. Estimated value of the largest subsequent contract 54.684,00 lei excluding VAT. Minimum estimated quantity under the framework agreement 12.000 syringes. Minimum estimated value of the framework agreement 1.093.680,00 lei excluding VAT. Maximum estimated quantity under the framework agreement 15.000 syringes. Maximum estimated value of the framework agreement 1.367.100,00 lei excluding VAT. Orders will be placed depending on stock and requirements. EPOETINUM ALFA 2000 UI/1 ml. Estimated quantity for the largest subsequent contract 300 syringes. Estimated value of the largest subsequent contract 14.241,00 lei excluding VAT. Minimum estimated quantity under the framework agreement 6.000 syringes. Minimum estimated value of the framework agreement 284.820,00 lei excluding VAT. Maximum estimated quantity under the framework agreement 8.000 syringes. Maximum estimated value of the framework agreement 379.760,00 lei excluding VAT. Orders will be placed depending on stock and requirements. SEVELAMER CARBONATE 800 mg. Estimated quantity for the largest subsequent contract 5.400 tablets. Estimated value of the largest subsequent contract 9.558,00 lei excluding VAT. Minimum estimated quantity under the framework agreement 115.000,00 tablets. Minimum estimated value of the framework agreement 203.550,00 lei excluding VAT. Maximum estimated quantity under the framework agreement 130.000 tablets. Maximum estimated value of the framework agreement 230.100,00 lei excluding VAT. Orders will be placed depending on stock and requirements. Procedure: open. Estimated value: 2,343,860 RON. Review the original TED notice for the complete requirement, lots, amendments and attachments.